Related Experiment Video
Updated: Jan 6, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs are a key factor in the globalization of tumor-host relationships
1R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine.
Abstract:
A new round of molecular oncology development in the post-genomic era significantly changes the conventional understanding of the nature and origin of the malignant process. Increasingly, fundamental phenomena are emerging that change the "canonical" views of the dominant role of gene mutations that contribute to the uncontrolled proliferation and emergence of heterogeneous malignant cells. Recent numerous studies have shown that significant variability in the initiation, proliferation and control of the apoptotic program of tumor cells is due to numerous epigenetic processes, including the level of expression of microRNAs (miRNAs). This paper reviews the literature data and presents the results of own research in which miRNAs have been found to form a molecular phenotype for malignancy. Their role as a "conductor" of the functioning of a genetic-epigenetic orchestra that coordinates various aspects of malignancy has been suggested. MiRNAs have been shown to be an active participant in balancing mechanisms in the development of controversial processes in breast cancer cell lines of varying degrees of malignancy. The analysis of the literature data and the own studies of the expression profile of only a few miRNAs suggests that scientists and clinicians have received a new marker and a target that simultaneously plays the role of an active insider in both the oncogene-oncosuppressor relationship and in the globalization of this process at the tumor-host level. Further investigation of the "alarm" marker in this network will allow to reconsider the molecular genetic classification of neoplastic disease, which will provide the development of a new strategy for cancer therapy.
Insights
MicroRNAs (miRNAs) are emerging as key regulators in cancer, influencing tumor development beyond gene mutations. These molecules act as conductors in the genetic-epigenetic orchestra, offering new therapeutic targets and diagnostic markers for malignancy.
Area of Science:
- Molecular Oncology
- Epigenetics
- Cancer Biology
Background:
- The post-genomic era is shifting cancer research focus from gene mutations to epigenetic factors.
- MicroRNAs (miRNAs) are increasingly recognized for their role in regulating gene expression and cellular processes, including cancer development.
Purpose of the Study:
- To review literature and present research on the role of miRNAs in forming the molecular phenotype of malignancy.
- To explore miRNAs as conductors of genetic-epigenetic interactions in cancer.
- To investigate miRNAs as potential diagnostic markers and therapeutic targets in cancer.
Main Methods:
- Literature review of molecular oncology and epigenetic studies.
- Analysis of miRNA expression profiles in breast cancer cell lines.
- Comparative analysis of miRNA roles in varying degrees of malignancy.
Main Results:
- MiRNAs significantly influence tumor cell initiation, proliferation, and apoptosis control.
- MiRNAs act as a "conductor" coordinating genetic and epigenetic factors in malignancy.
- MiRNAs are involved in balancing mechanisms in breast cancer cell lines.
- Specific miRNA expression profiles serve as markers for malignancy.
Conclusions:
- MiRNAs are crucial players in cancer development, impacting oncogene-oncosuppressor relationships and tumor-host interactions.
- MiRNAs represent a novel class of biomarkers and therapeutic targets in oncology.
- Further research into miRNA networks may lead to a reclassification of neoplastic diseases and new cancer therapies.
Related Concept Videos
The Tumor Microenvironment
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

